Evelyn van den Tweel

Neuroprotection by Selective Nitric Oxide Synthase Inhibition at 24 Hours After Perinatal Hypoxia-Ischemia

Cacha Peeters‐Scholte, Johanna G. Koster, Wouter B. Veldhuis et al. · Stroke · 2002 · 107 citations · Full text

LBA15 Primary outcome of the phase III SYD985.002/TULIP trial comparing [vic-]trastuzumab duocarmazine to physician’s choice treatment in patients with pre-treated HER2-positive locally advanced or metastatic breast cancer

C. Saura Manich, Joyce O’Shaughnessy, Philippe Aftimos et al. · Annals of Oncology · 2021 · 103 citations

Metastatic Breast Cancer, Breast Oncology, Medicine +7

Hypoxia/Ischemia Modulates G Protein–Coupled Receptor Kinase 2 and β-Arrestin-1 Levels in the Neonatal Rat Brain

Maria Stella Lombardi, Evelyn van den Tweel, Annemieke Kavelaars et al. · Stroke · 2004 · 50 citations · Full text

Pharmacological interventions in the newborn piglet in the first 24 h after hypoxia-ischemia

Cacha Peeters‐Scholte, Evelyn van den Tweel, Tomoaki Ioroi et al. · Experimental Brain Research · 2002 · 27 citations

Animal Physiology, Newborn Piglet, First 24 +12

Trastuzumab Duocarmazine in Pretreated Human Epidermal Growth Factor Receptor 2–Positive Advanced or Metastatic Breast Cancer: An Open-Label, Randomized, Phase III Trial (TULIP)

Nicholas C. Turner, Cristina Saura, Philippe Aftimos et al. · Journal of Clinical Oncology · 2024 · 27 citations · Full text